Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies

BACKGROUND: Maintenance of effect following treatment with galcanezumab compared to placebo in adult patients with episodic or chronic migraine was evaluated. METHODS: In 2 similarly designed studies of patients with episodic migraine (6 months) and 1 study of patients with chronic migraine (3 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Förderreuther, Stefanie, Zhang, Qi, Stauffer, Virginia L., Aurora, Sheena K., Láinez, Miguel J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755564/
https://www.ncbi.nlm.nih.gov/pubmed/30594122
http://dx.doi.org/10.1186/s10194-018-0951-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755564/
https://www.ncbi.nlm.nih.gov/pubmed/30594122
http://dx.doi.org/10.1186/s10194-018-0951-2

Ejemplares similares